Elisa Andrini

688 total citations
36 papers, 412 citations indexed

About

Elisa Andrini is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elisa Andrini has authored 36 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 17 papers in Epidemiology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elisa Andrini's work include Lung Cancer Research Studies (19 papers), Neuroendocrine Tumor Research Advances (17 papers) and Lung Cancer Treatments and Mutations (9 papers). Elisa Andrini is often cited by papers focused on Lung Cancer Research Studies (19 papers), Neuroendocrine Tumor Research Advances (17 papers) and Lung Cancer Treatments and Mutations (9 papers). Elisa Andrini collaborates with scholars based in Italy, United States and Iran. Elisa Andrini's co-authors include Giuseppe Lamberti, Andrea Ardizzoni, Alessandro Di Federico, Francesco Gelsomino, Alessandro Rizzo, Claudia Parisi, Davide Campana, Biagio Ricciuti, Cristina Mosconi and G. Siepe and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Drug Delivery Reviews and International Journal of Molecular Sciences.

In The Last Decade

Elisa Andrini

29 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Andrini Italy 11 287 175 114 102 63 36 412
Rie Sakakibara Japan 10 376 1.3× 264 1.5× 114 1.0× 115 1.1× 67 1.1× 27 528
Xiaoyang Zhai China 10 305 1.1× 180 1.0× 112 1.0× 84 0.8× 57 0.9× 33 448
J. Laird United States 10 428 1.5× 160 0.9× 242 2.1× 186 1.8× 62 1.0× 17 605
Jinluan Li China 14 361 1.3× 213 1.2× 65 0.6× 76 0.7× 89 1.4× 43 516
Joanna Huszno Poland 11 193 0.7× 146 0.8× 131 1.1× 40 0.4× 102 1.6× 37 425
Laura Mansi France 12 228 0.8× 94 0.5× 85 0.7× 34 0.3× 80 1.3× 30 373
Victoria Ebiana United States 7 592 2.1× 253 1.4× 150 1.3× 328 3.2× 35 0.6× 8 665
Melanie Demes Germany 10 160 0.6× 106 0.6× 58 0.5× 77 0.8× 36 0.6× 30 311
Kristin Kathleen Ancell United States 10 540 1.9× 155 0.9× 98 0.9× 50 0.5× 30 0.5× 16 653
Yasuyoshi Sato Japan 11 187 0.7× 102 0.6× 75 0.7× 28 0.3× 36 0.6× 47 380

Countries citing papers authored by Elisa Andrini

Since Specialization
Citations

This map shows the geographic impact of Elisa Andrini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Andrini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Andrini more than expected).

Fields of papers citing papers by Elisa Andrini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Andrini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Andrini. The network helps show where Elisa Andrini may publish in the future.

Co-authorship network of co-authors of Elisa Andrini

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Andrini. A scholar is included among the top collaborators of Elisa Andrini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Andrini. Elisa Andrini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andrini, Elisa, Rita Rinaldi, Tania Silvestri, et al.. (2025). Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities. Frontiers in Immunology. 16. 1681765–1681765.
2.
Pusceddu, Sara, Fabio Gelsomino, Anna La Salvia, et al.. (2025). Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids. Endocrine. 88(2). 660–667.
3.
Palloni, Andrea, Simona Tavolari, Chiara Deiana, et al.. (2025). Classic versus innovative strategies for immuno-therapy in pancreatic cancer. Advanced Drug Delivery Reviews. 225. 115671–115671. 1 indexed citations
4.
5.
Campana, Davide, et al.. (2025). Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine Neoplasms. Current Oncology. 32(2). 113–113.
6.
Panzuto, Francesco, Elisa Andrini, Giuseppe Lamberti, et al.. (2024). Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort. Journal of Clinical Medicine. 13(7). 2074–2074. 4 indexed citations
7.
8.
Mosconi, Cristina, Claudio Malizia, Davide Campana, et al.. (2024). β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients. Journal of Clinical Medicine. 13(13). 3841–3841. 1 indexed citations
9.
10.
Andrini, Elisa, Annalisa Altimari, Elisa Gruppioni, et al.. (2024). Challenges and future perspectives for the use of temozolomide in the treatment of SCLC. Cancer Treatment Reviews. 129. 102798–102798. 4 indexed citations
11.
Brighi, Nicole, Giuseppe Lamberti, Elisa Andrini, et al.. (2023). Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors. Current Oncology. 30(2). 1381–1394. 11 indexed citations
12.
Lamberti, Giuseppe, Natalie Prinzi, Alberto Bongiovanni, et al.. (2023). Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET). Diagnostics. 13(9). 1595–1595. 3 indexed citations
13.
Gelsomino, Francesco, Rita Rinaldi, Lorenzo Muccioli, et al.. (2023). Peripheral nervous system adverse events associated with immune checkpoint inhibitors. Journal of Neurology. 270(6). 2975–2986. 28 indexed citations
14.
Andrini, Elisa, et al.. (2023). Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review. Journal of Clinical Medicine. 12(2). 717–717. 17 indexed citations
15.
Andrini, Elisa, Giuseppe Lamberti, Laura Alberici, Claudio Ricci, & Davide Campana. (2023). An Update on Appendiceal Neuroendocrine Tumors. Current Treatment Options in Oncology. 24(7). 742–756. 6 indexed citations
16.
Andrini, Elisa, et al.. (2022). Non-small-cell lung cancer: how to manage RET-positive disease. Drugs in Context. 11. 1–12. 10 indexed citations
17.
18.
Mollica, Veronica, Alessandro Rizzo, Matteo Rosellini, et al.. (2021). Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art. Cancers. 13(3). 546–546. 37 indexed citations
19.
Andrini, Elisa, G. Siepe, Cristina Mosconi, et al.. (2021). Multimodal Strategy in Localized Merkel Cell Carcinoma: Where Are We and Where Are We Heading?. International Journal of Molecular Sciences. 22(19). 10629–10629. 3 indexed citations
20.
Ricciuti, Biagio, Giuseppe Lamberti, Elisa Andrini, et al.. (2019). Antibody–drug conjugates for lung cancer in the era of personalized oncology. Seminars in Cancer Biology. 69. 268–278. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rie Sakakibara Breakdown of academic impact, for papers by Xiaoyang Zhai Breakdown of academic impact, for papers by J. Laird Breakdown of academic impact, for papers by Jinluan Li Breakdown of academic impact, for papers by Joanna Huszno Breakdown of academic impact, for papers by Laura Mansi Breakdown of academic impact, for papers by Victoria Ebiana Breakdown of academic impact, for papers by Melanie Demes Breakdown of academic impact, for papers by Kristin Kathleen Ancell Breakdown of academic impact, for papers by Yasuyoshi Sato
Rankless by CCL
2026